It was a good week for Scotland's life sciences sector last week, with two separate developments promising to help turn innovation into financial gain. First, the Scottish Centre for Genomic Technology and Informatics (GTI) launched a £4.5 million project to support the commercialization of scientific breakthroughs, and then the Korea Health Industry Development Institute (KHIDI) established a Scottish office to manage a multimillion-pound investment in drug development research.

"We are very interested in stimulating better two-way interaction between the academic and private sector," said Peter Ghazal, Director of GTI, whose initiative is being funded by Scottish Enterprise, the European Regional Development Fund, and The University of Edinburgh.

Ghazal himself spent 16 years working in the United States before moving to Scotland 3 years ago. His analysis of the Scottish bioscience sector suggests there are many good scientific initiatives but some need more of a US-style approach to...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?